19 July 2020 : Database Analysis
Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
Chuan Hu1ABCEF*, Yuanhe Wang1ABC, Chuan Liu2DEF, Rui Shen1DE, Bo Chen3F, Kang Sun1B, Huili Rao4C, Lin Ye3E, Jianjun Ye3C, Shaoqi Tian1ABCDEFDOI: 10.12659/MSM.924126
Med Sci Monit 2020; 26:e924126
Figure 4 The nomograms and corresponding results showed the prognostic value of AS events and clinicopathologic data. (A) Nomogram for predicting OS in the SARC cohort. (B) Time-dependent ROC curves for 3- (red), 5- (green), and 7- (blue) year OS. (C) Calibration plot of the AS-clinicopathologic nomogram in terms of the agreement between nomogram-predicted and observed 3- (red), 5- (green), and 7- (blue) year OS in the SARC cohort. (D) Decision curve analysis of the AS-clinicopathologic nomogram for 3- (red), 5- (green), and 7- (blue) year risk in the SARC cohort. AS – alternative splicing; OS – overall survival; SARC – sarcoma; ROC – receiver operating characteristic.